Fusion Pharmaceuticals Inc.
$75,000.00 CAD
≈ 12 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2018-2019
- Agreement period
- October 1, 2018 – September 30, 2019
- Reference
- nrc-cnrc:172-2018-2019-Q4-914681
Published purpose
Fusion Pharmaceuticals, Inc. is a new Canadian pharmaceutical company that develops innovative targeted radiotherapy drugs. The project is focused on studying the synergistic effects of Fusion’s targeted radiotherapies with immunotherapies to create new cancer treatment strategies and expand investment and commercialization opportunities for Fusion.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions